Empress Therapeutics

Founded by Flagship Pioneering in 2020, Empress Therapeutics generates good medicines, fast, by starting with chemistry inside the human body. The Empress Chemilogics™ platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body to create first- or best-in-class oral medicines for a broad range of diseases quickly, predictably, and cost-effectively.

Content by Empress Therapeutics

An illustration of a blue capsule with particles resembling molecules dispersing from it

| 5 min read

byEmpress Therapeutics

How AI is unlocking new biological pathways and therapies

AI helps researchers reveal unexpected connections between human diseases and biological pathways, bringing new therapeutic insights.

Industry Perspectives

Page 1 of 1 - 1 Total Items

Sponsored

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.

Computational approaches to drug design

Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.

Compendium